Nanjing, China

Sheng Guo

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Nanjing University of Chinese Medicine. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sheng Guo. Retrieved from https://idiyas.com/inventor/sheng-guo-wxncdxtu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 7.2

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Sheng Guo

Introduction

Sheng Guo is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of medicinal chemistry and agricultural biotechnology. With a total of 3 patents, his work focuses on developing compounds with potential therapeutic applications and innovative agricultural solutions.

Latest Patents

Sheng Guo's latest patents include a groundbreaking invention titled "(9beta-H)-pimarane mother nucleus diterpenoid compound with anti-colon cancer activity and derivative thereof." This invention discloses a (9β-H)-pimarane skeleton diterpenoid with anti-colon cancer activity, along with its preparation method and applications. The research indicates that the novel compounds exhibit inhibition effects on colon cancer cells, with one compound demonstrating remarkable anti-proliferation effects on two colon cancer cell lines, HT-29 and SW620. These effects are stronger than those of the positive drug 5-fluorouracil, suggesting the potential for developing a new anti-colon cancer drug.

Another notable patent is related to a microbial agent aimed at preventing and controlling early bolting in crops. This invention describes a strain separation method and the preparation of a microbial agent derived from rhizosphere soil. The strain, identified through Microbial 16S rDNA sequencing, has been deposited at the China Center for Type Culture Collection. The XG3 strain can promote seed germination and delay flowering, while also increasing root weight, diameter, and rootlet number, effectively preventing early bolting.

Career Highlights

Sheng Guo is affiliated with the Nanjing University of Chinese Medicine, where he conducts research and develops innovative solutions in his field. His work has garnered attention for its potential impact on cancer treatment and agricultural practices.

Collaborations

Sheng Guo collaborates with esteemed colleagues, including Jinao Duan and Pei Liu, to further advance research and innovation in his areas of expertise.

Conclusion

Sheng Guo's contributions to medicinal chemistry and agricultural biotechnology highlight his role as an influential inventor. His innovative patents demonstrate the potential for significant advancements in both health and agriculture.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…